Kane Biotech (CVE:KNE) Stock Price Down 3.7%

Shares of Kane Biotech Inc (CVE:KNE) dropped 3.7% during mid-day trading on Monday . The stock traded as low as C$0.13 and last traded at C$0.13, approximately 12,500 shares changed hands during trading. A decline of 80% from the average daily volume of 62,500 shares. The stock had previously closed at C$0.14.

The company has a debt-to-equity ratio of 3,077.59, a current ratio of 0.82 and a quick ratio of 0.62. The company has a 50 day simple moving average of C$0.14 and a 200-day simple moving average of C$0.11. The stock has a market cap of $11.22 million and a P/E ratio of -11.82.

About Kane Biotech (CVE:KNE)

Kane Biotech Inc, a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops pet oral care solutions under the StrixNB and bluestem trademarks; animal and human wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; and shampoo for dogs, cats, and horses under the Alosera trademark.

Read More: What is a Reverse Stock Split?

Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.